Gefitinib has a more favorable tolerability profile and less adverse effect than traditional chemotherapy agents in the treatment of tumor since it aim directly at tumour cells.

• 与传统化疗药物相比，吉非替尼具有瞄准特定的分子靶点、不良反应小和特异性强等优点。